Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Clinical Pharmacology and Therapeutics|March 1, 1991
Intraocular pressure increases with fenoldopam, but not nitroprusside, in hypertensive humansW J Elliott, T A Karnezis, R A Silverman, et al.
Prostaglandins|December 1, 1984
Effects of intravenous infusions of prostaglandin D2 in manD J Heavey, P Lumley, S E Barrow, et al.
The Journal of Biological Chemistry|July 31, 2001
Werner syndrome protein is regulated and phosphorylated by DNA-dependent protein kinaseS M Yannone, S Roy, D W Chan, et al.
British Journal of Clinical Pharmacology|January 1, 1988
Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patientsR R Weber, C E McCoy, J A Ziemniak, et al.
Circulation|December 1, 1987
Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine1 agonist fenoldopamM B Murphy, C E McCoy, R R Weber, et al.
Experimental Eye Research|November 1, 1988
Effects of selective dopamine-1 receptor activation on intraocular pressure in manT A Karnezis, M B Murphy, R R Weber, et al.
Journal of Clinical Pharmacology|June 1, 1993
Fenoldopam mesylate versus sodium nitroprusside in the acute management of severe systemic hypertensionB L Pilmer, J A Green, E A Panacek, et al.
The American Journal of Cardiology|August 11, 1988
Role of the beta 2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochlorideR M Lang, K M Borow, A Neumann, et al.
Circulation|March 1, 1990
Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertensionW J Elliott, R R Weber, K S Nelson, et al.
Environment International|April 1, 2011
Distribution, fate and risk assessment of antibiotics in sewage treatment plants in Hong Kong, South ChinaH W Leung, T B Minh, M B Murphy, et al.
Pageof 11